Back to top


RHD Action Small Grant Update: Zambia

27 February 2018

Last year, RHD Action awarded one of its small grants to Drs John Musuku, Mwansa Ketty Lubeya, and Mercy Imakando at University Teaching Hospitals in Lusaka, Zambia for a project aimed at increasing awareness to promote sexual and reproductive health among adolescents and women living with rheumatic heart disease (RHD).

Read More »

RHD Action Small Grant Program Update: Kenya

16 January 2018

Ms Dilys Kemunto Nyariki, a sixth-year medical student at Moi University, School of Medicine in Eldoret, Kenya was the project lead on behalf of the Eldoret Chapter of the Young Professionals Chronic Disease Network (YPCDN) for the project entitled, “Hearts to Hearts: A Rheumatic Heart Disease (RHD) Awareness Campaign.” This is the second RHD Action Small Grant recipient to complete their project and a report of their accomplishments follows.

Read More »

A Passion for Patient Advocacy

12 January 2018

Christine and Flavia are both from Uganda and as well as living with rheumatic heart disease they also have a shared passion for patient advocacy.

Read More »

RHD Action Small Grant Program Update: Fiji

13 December 2017

Launched this year, the RHD Action Small Grants Program funded five project proposals in low-and-middle income countries across the globe to support groups who are already addressing the work of RHD and to bring the work of key RHD stakeholders under the RHD Action banner. Successful applicants were awarded $2000 with the expectation that that the activity would be completed within six-months.  

Read More »

New updates planned for TIPs – Seeking Chapter Reviewers

13 December 2017

RHD Action are updating our Tools for Implementing RHD Control Programs (TIPs) resource. TIPs was first published in 2014 and provides a framework for program managers and RHD program staff to develop control programs. TIPs has now be used worldwide to help structure decisions about program design and care delivery.

Read More »

RhEACH welcome new Deputy Director

05 December 2017

After three years as Deputy Director of RhEACH, Dr Rosemary Wyber is moving into a new role as the Head of Strategy for END RHD in Australia. As the inaugural RhEACH Deputy Director, Rosemary has been instrumental in establishing the work of RhEACH and the broader RHD Action initiative, including driving key activities such as the development of TIPs. Taking over the role of Deputy Director of RhEACH is Dr Sophie La Vincente, who has been the RhEACH Senior Technical Advisor since May 2017.

Read More »

Applications Now Open for WHF Emerging Leaders Programme

28 November 2017

The Emerging Leaders Programme has been created by the World Heart Federation to form and develop a long-term cadre of experts who collaborate, research, and act to reduce premature mortality from cardiovascular disease (CVD) globally by at least 25% by 2025 as targeted by the World Heart Federation and World Health Organization (25by25).

Read More »

National & International Partners Convene in Kampala for RHD Stakeholder Meeting

17 November 2017

“RHD is a big problem here – it causes a lot of mortality. We have convened this meeting to find a way forward”, said Dr Emmy Okello, adult interventional cardiologist at the Uganda Heart Institute, in his opening remarks to the RHD Uganda Stakeholders’ Meeting.

Read More »

Listen to my Heart – Patient Awareness Event in Kampala

13 November 2017

On 1st November 2017, the Uganda Heart Institute (UHI) Rheumatic Heart Disease Support Group and RHD Action hosted an interactive event entitled ‘Listen to my Heart’ at the Mulago Guest House in Kampala, Uganda.

Read More »

World Antibiotic Awareness Week - Q&A with Dr Asha Bowen

12 November 2017

Dr Asha Bowen is a Paediatric Infectious Diseases Specialist at Princess Margaret Hospital for Children in Perth, Western Australia. She is also a Research Fellow with the Wesfarmers Centre for Vaccines and Infectious Diseases at the Telethon Kids Institute. To mark World Antibiotic Awareness Week she recently joined us for a short Q&A to talk about antibotics used for group A streptococcal infections, and important considerations when using antibiotics for rheumatic fever and rheumatic heart disease (RHD).

Read More »